Evidence map›Paper›PMID 25865368›Full record

ArticleCell host & microbe2015

The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development.

Shu Mei Teo, Danny Mok, Kym Pham, Merci Kusel, Michael Serralha, Niamh Troy, Barbara J Holt, Belinda J Hales, Michael L Walker, Elysia Hollams and 8 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05063149 (Protecting Late-moderate Preterm Infants From Respiratory Tract Infections and Wheeze in Their First Years of Life by Using Bacterial Lysates.), which is not on this map. Cited by 557 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
557citing papers in PubMed, 4 pooled it
125.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05063149 phase3recruitingnot on this mapstarted 2022, after this paper: background citation

Protecting Late-moderate Preterm Infants From Respiratory Tract Infections and Wheeze in Their First Years of Life by Using Bacterial Lysates.

TypeinterventionalSponsorFranciscus GasthuisRan2022 to 2026Enrolled500ConditionsWheezing, LRTI, PrematureArmsBroncho-Vaxom, Placebo
3 · Its place in the literature

Who cites it

557 citing papers in PubMed, 4 syntheses or guidelines pooled it, 952 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Journal of bacteriology · 2026
    Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Gingipain proteases from the bacteriumProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  20. Article

497 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Shu Mei TeoMedical Systems Biology, Department of Pathology and Department of Microbiology & Immunology, The University of Melbourne, Parkville, VIC 3010, Australia; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3010, Australia.
Danny MokTelethon Kids Institute, The University of Western Australia, West Perth, WA 6008, Australia.
Kym PhamMelbourne Translational Genomics Platform, Department of Pathology, The University of Melbourne, Parkville, VIC 3010, Australia.
Merci KuselTelethon Kids Institute, The University of Western Australia, West Perth, WA 6008, Australia.
Michael SerralhaTelethon Kids Institute, The University of Western Australia, West Perth, WA 6008, Australia.
Niamh TroyTelethon Kids Institute, The University of Western Australia, West Perth, WA 6008, Australia.
Barbara J HoltTelethon Kids Institute, The University of Western Australia, West Perth, WA 6008, Australia.
Belinda J HalesTelethon Kids Institute, The University of Western Australia, West Perth, WA 6008, Australia.
Michael L WalkerMedical Systems Biology, Department of Pathology and Department of Microbiology & Immunology, The University of Melbourne, Parkville, VIC 3010, Australia.
Elysia HollamsTelethon Kids Institute, The University of Western Australia, West Perth, WA 6008, Australia.
Yury A BochkovDepartment of Internal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA.
Kristine GrindleDepartment of Internal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA.
Sebastian L JohnstonAirway Disease Infection Section and MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, National Heart and Lung Institute, Imperial College London, Norfolk Place, London W2 1PG, UK.
James E GernDepartment of Internal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI 53726, USA.
Peter D SlyQueensland Children's Medical Research Institute, The University of Queensland, Brisbane, QLD 4059, Australia.
Patrick G HoltTelethon Kids Institute, The University of Western Australia, West Perth, WA 6008, Australia; Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, QLD 4059, Australia.
Kathryn E HoltDepartment of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC 3010, Australia. Electronic address: kholt@unimelb.edu.au.
Michael InouyeMedical Systems Biology, Department of Pathology and Department of Microbiology & Immunology, The University of Melbourne, Parkville, VIC 3010, Australia. Electronic address: minouye@unimelb.edu.au.
The Kids Research Institute Australia · AUThe University of Melbourne · AUUniversity of Wisconsin–Madison · USChildren's Medical Research Institute · AUAsthma UK · GB

Funding

Virus-Bacterial Interactions and Exacerba of AsthmaP01HL070831 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E. · 2002 to 2017
$31.3M
Wisconsin Infant Study Cohort (WISC)U19AI104317 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI Irene M Ong · 2013 to 2026
$22.5M
RV-Mediated Mechanisms of Neutrophil Motility /InflammatU19AI070503 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E. · 2006 to 2010
$6.8M
Medical Research Council G1000758NHLBI NIH HHS P01 HL070831NIAID NIH HHS U19 AI070503NIAID NIH HHS U19 AI104317
6 · The paper itself

Abstract

The nasopharynx (NP) is a reservoir for microbes associated with acute respiratory infections (ARIs). Lung inflammation resulting from ARIs during infancy is linked to asthma development. We examined the NP microbiome during the critical first year of life in a prospective cohort of 234 children, capturing both the viral and bacterial communities and documenting all incidents of ARIs. Most infants were initially colonized with Staphylococcus or Corynebacterium before stable colonization with Alloiococcus or Moraxella. Transient incursions of Streptococcus, Moraxella, or Haemophilus marked virus-associated ARIs. Our data identify the NP microbiome as a determinant for infection spread to the lower airways, severity of accompanying inflammatory symptoms, and risk for future asthma development. Early asymptomatic colonization with Streptococcus was a strong asthma predictor, and antibiotic usage disrupted asymptomatic colonization patterns. In the absence of effective anti-viral therapies, targeting pathogenic bacteria within the NP microbiome could represent a prophylactic approach to asthma.

Indexed as

MicrobiotaAsthmaHumansInfantLongitudinal StudiesNasopharynxRespiratory Tract InfectionsRisk Assessment

Identifiers

PMID25865368
PMCPMC4433433
OpenAlexW2100589529

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.